The role of ESRP1 in solid tumor development through the regulation of CD44 splicing and EMT processes
According to the World Health Organization’s statistics, cancer is the second leading cause of death worldwide, following cardiovascular diseases. Despite significant progress in the field of cancer treatment in recent years, cancer remains one of the main factors shortening human life expectancy. T...
Saved in:
Main Authors: | Lili Wang, Min Zhang, Lei Ke Zhao, Xiaohan Yuan, Houyu Zhao, Yanting Liu, Yinghua Ji, Ping Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1451130/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic Characterization of Splicing Dysregulation in Pan Solid Tumor Transcriptome
by: Jingru Sui, et al.
Published: (2025-01-01) -
Alternative Splicing: Emerging Roles in Anti-Aging Strategies
by: Lingyue Gao, et al.
Published: (2025-01-01) -
Targeting RNA splicing modulation: new perspectives for anticancer strategy?
by: Xuemei Lv, et al.
Published: (2025-01-01) -
Assessment of Immuno-histochemical Expression of CD44 in Renal Tumors
by: Banan Mohammed, et al.
Published: (2025-01-01) -
Antigen-Independent Maturation of CD2, CD11a/CD18,CD44, and CD58 Expression on Thymic Emigrants inFetal and Postnatal Sheep
by: Deborah A. Witherden, et al.
Published: (1995-01-01)